SCHEMBL29516197

SCHEMBL29516197

Cc1ccccc1Oc1nc(N)nc2c1CCCC2(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 6/20 0.42
▸ BCHE P06276 5/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MAP4K4 O95819 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ HTR7 P34969 1/20 0.33
▸ HTR6 P50406 1/20 0.33
▸ DHFR P00374 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287332 1.00 ACHE (0.42) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL24287268 0.87 TP53 (0.40) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL26813118 0.82 ACHE (0.36) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL24287264 0.81 ACHE (0.41) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL24287272 0.76 ACHE (0.41) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL24287270 0.76 ACHE (0.41) ACHEBCHESMN1; SMN2HPGDALDH1A1
SCHEMBL24287762 0.73 KDM4E (0.50) HPGDALDH1A1CYP1A2NPC1
SCHEMBL24287460 0.72 EEF2K (0.32) —
SCHEMBL26813358 0.71 HTR1A (0.36) SMN1; SMN2HPGDALDH1A1MEN1KMT2A
SCHEMBL24287263 0.70 TP53 (0.40) ACHEBCHESMN1; SMN2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225750-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback